Proton therapy for treatment of intracranial benign tumors in adults: A systematic review

Archive ouverte

Lesueur, Paul | Calugaru, Valentin | Nauraye, Catherine | Stefan, Dinu | Cao, Kim | Emery, Evelyne | Reznik, Yves | Habrand, Jean Louis | Tessonnier, Thomas | Chaikh, Abdulhamid | Balosso, Jacques | Thariat, Juliette

Edité par CCSD ; WB Saunders -

International audience. IntroductionThe depth-dose distribution of a proton beam, materialized by the Bragg peak makes it an attractive radiation modality as it reduces exposure of healthy tissues to radiations, compared with photon therapy Prominent indications, based on a long-standing experience are: intraocular melanomas, low-grade skull-base and spinal canal malignancies. However, many others potential indications are under investigations such as the benign morbid conditions that are compatible with an extended life-expectancy: low grade meningiomas, paragangliomas, pituitary adenomas, neurinomas craniopharyngioma or recurrent pleomorphic adenomas.MaterialsGiven the radiation-induced risk of secondary cancer and the potential neurocognitive and functional alteration with photonic radiotherapy, we systematically analyzed the existing clinical literature about the use of proton therapy as an irradiation modality for cervical or intracranial benign tumors. The aim of this review was to report clinical outcomes of adult patients with benign intracranial or cervical tumors treated with proton therapy and to discuss about potential advantages of proton therapy over intensity modulated radiotherapy or radiosurgery.ResultsTwenty-four studies were included. There was no randomized studies. Most studies dealt with low grade meningiomas (n = 9). Studies concerning neurinoma (n = 4), pituitary adenoma (n = 5), paraganglioma (n = 5), or craniopharyngioma (n = 1) were fewer. Whatever the indication, long term local control was systematically higher than 90% and equivalent to series with conventional radiotherapy.ConclusionProton-therapy for treatment of adult benign intracranial and cervical tumors is safe. Randomized or prospective cohorts with long term cognitive evaluations are needed to assess the real place of proton-therapy in the treatment of adults benign head and neck tumors.

Consulter en ligne

Suggestions

Du même auteur

Proton therapy for adult-type diffuse glioma: a systematic review

Archive ouverte | Goliot, Nicolas | CCSD

CERVOXY. International audience. BackgroundWe conducted a systematic review to evaluate outcomes and toxicities associated with proton therapy in the treatment of adult-type diffuse glioma.MethodsFollowing PRISMA gu...

Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer)

Archive ouverte | Lesueur, Paul | CCSD

International audience. BackgroundUntil 50% of patients with renal cancer or melanoma, develop brain metastases during the course of their disease. Stereotactic radiotherapy has become a standard of care for patient...

Prospective Assessment of Early Proton Therapy-Induced Optic Neuropathy in Patients With Intracranial, Orbital or Sinonasal Tumors: Impact of A Standardized Ophthalmological Follow Up

Archive ouverte | Lecornu, Marie | CCSD

CERVOXY CLIN. International audience. Purpose Proton therapy (PT) can be a good option to achieve tumor control while reducing the probability of radiation induced toxicities compared to X-ray-based radiotherapy. Ho...

Chargement des enrichissements...